Julia Marie Eastland, CEO & President at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 28,500 shares at $1.73 ($49K) on 2025-01-31, disclosed to the SEC on 2025-02-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.